Tuberculosis transmission and screening strategies

Poster Discussion
Chairs: D. Goletti (Roma (RM), Italy), P. Escalante (Rochester, United States of America)

Associated factors to tuberculosis transmission. J. Garcia Garcia (Barcelona, Spain), T. Rodrigo (Barcelona, Spain), J. Ruiz-Manzano (Barcelona, Spain), M. Casals (Barcelona, Spain), J. Rodriguez-Lopez (Avilés. Asturias, Spain), J. Caylà (Barcelona, Spain), P. Grupo De Tubeculosis-Separ (Barcelona, Spain)
Introduction of a Latent TB infection (LTBI) screening programme detects cases of active tuberculosis and hepatitis B and C J. Yung (London, United Kingdom), G. Isbister (London, United Kingdom), T. Mason (London, United Kingdom), S. Abiona (London, United Kingdom), M. Dall’Antonia (London, United Kingdom), M. Belton (London, United Kingdom)
Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital N. Vasileva (St. Petersburg, Russian Federation), A. Vyazovaya (St. Petersburg, Russian Federation), I. Vasilev (St. Petersburg, Russian Federation), N. Solovieva (St. Petersburg, Russian Federation), V. Zhuravlev (St. Petersburg, Russian Federation), O. Narvskaya (St. Petersburg, Russian Federation), L. Zueva (St. Petersburg, Russian Federation)
Diagnostic delay in tuberculosis in Yorkshire & Humber, UK: 2013-16 data S. Gissing (Leeds, United Kingdom), R. Bindra (Leeds, United Kingdom)
Implementation of FAST strategy in the National Center for Tuberculosis and Lung Diseases (NCTLD) in Georgia N. Kiria (Tbilisi, Georgia), Z. Avaliani (Tbilisi, Georgia), R. Aspindzelashvili (Tbilisi, Georgia), N. Lomtadze (Tbilisi, Georgia)
Tuberculosis contact investigation – 5-year experience of a Portuguese ambulatory center D. Pereira Duarte (Torres Vedras, Portugal), R. Farinha (Torres Vedras, Portugal), J. Eusébio (Torres Vedras, Portugal), P. Raimundo (Torres Vedras, Portugal), N. André (Torres Vedras, Portugal), A. Domingos (Torres Vedras, Portugal)
Evaluation of IP-10 in IGRA for LTBI diagnosis L. Petrone (Rome, Italy), E. Petruccioli (Rome, Italy), V. Vanini (Rome, Italy), T. Chiacchio (Rome, Italy), G. Cuzzi (Rome, Italy), F. Palmieri (Rome, Italy), G. Ippolito (Rome, Italy), D. Goletti (Rome, Italy)
Modulation of whole-blood IGRA response in patients with latent TB infection during treatment E. Petruccioli (ROME, Italy), T. Chiacchio (ROME, Italy), V. Vanini (ROME, Italy), G. Cuzzi (ROME, Italy), F. Palmieri (ROME, Italy), L. Codecasa (MILAN, Italy), P. Castellotti (Milan, Italy), G. Ippolito (ROME, Italy), D. Goletti (ROME, Italy)
Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI? R. Francis (Nottingham, United Kingdom), A. Goodwin (Nottingham, United Kingdom), V. Navaratnam (Nottingham, United Kingdom), L. Dexter (Nottingham, United Kingdom), A. Rich (Nottingham, United Kingdom)
Immune reactive profiling in subjects at risk of latent tuberculosis infection with TST(+)/IGRA(-) results. P. Escalante (Rochester, MN, United States of America), T. Peikert (Rochester, MN, United States of America), V. Van Keulen (Rochester, MN, United States of America), C. Erskine (Rochester, MN, United States of America), A. Limper (Rochester, MN, United States of America)
Recombinant Tuberculosis Allergen in Detecting Latent Tuberculosis Infection in Adults T. Morozova (Saratov, Russian Federation), O. Otpuschennykova (Saratov, Russian Federation)
Results of retrospective-prospective comparison study of different immunologic tests in diagnosis of tuberculosis infection A. Starshinova (St-Petersburg , Russian Federation), V. Zhuravlev (St-Petersburg , Russian Federation), I. Dovgaluk (St-Petersburg , Russian Federation), A. Panteleev (St-Petersburg , Russian Federation), U. Zinchenko (St-Petersburg , Russian Federation), E. Istomina (St-Petersburg , Russian Federation), M. Pavlova (St-Petersburg , Russian Federation), P. Yablonskiy (St-Petersburg , Russian Federation)
Accuracy of whole blood IGRA in TB subjects with rheumatic disease. T. Chiacchio (Rome, Italy), E. Petruccioli (Rome, Italy), V. Vanini (Rome, Italy), G. Cuzzi (Rome, Italy), F. Palmieri (Rome, Italy), G. Ippolito (Rome, Italy), D. Goletti (Rome, Italy)
Comparison of LTBI screening strategies before TNF inhibitor treatment in inflammatory arthritis Y. JUNG (Seoul, Republic of Korea), D. Jeong (Seoul, Republic of Korea), J. Kang (Seoul, Republic of Korea), B. Yoo (Seoul, Republic of Korea), C. Lee (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), S. Hong (Seoul, Republic of Korea), T. Shim (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea)
Should we treat every patient with latent TB? Is there a cost to pay? U. Maqsood (Preston, United Kingdom), M. Ganaie (Stoke on Trent, United Kingdom), J. Redfern (Preston, United Kingdom), M. Munavvar (Preston, United Kingdom)
Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values? V. Sadovici-Bobeica (Chisinau, Republic of Moldova), V. Salaru (Chisinau, Republic of Moldova), L. Mazur-Nicorici (Chisinau, Republic of Moldova), M. Garabajiu (Chisinau, Republic of Moldova), T. Rotaru (Chisinau, Republic of Moldova), M. Mazur (Chisinau, Republic of Moldova)
Molecular Epidemiology of Tuberculosis (TB) Patients Attending to Ege University Faculty of Medicine I. Nesil (Izmir, Turkey), M. Ozhan (Izmir, Turkey), C. Cavusoglu (Izmir, Turkey)